Global Automatic Breast Ultrasound Diagnosis Systems Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global Automatic Breast Ultrasound Diagnosis Systems market size was valued at US$ 2206 million in 2024 and is forecast to a readjusted size of USD 3880 million by 2031 with a CAGR of 8.5% during review period.
Automated breast ultrasound diagnostic systems are used as an adjunct to mammography to screen for breast cancer in asymptomatic women with dense breasts. It is an effective screening modality that can differentiate between cysts, fibroadenomas, cancer or infection. The size of the lesion can be measured, the exact location is easily determined, or it can be precisely positioned for surgical procedures.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. The automated breast volume scanner (ABVS) segment is expected to hold the largest share during the forecast period, ABVS uses a scanner to precisely examine lactiferous ducts and evaluate breast volume images by high frequency ultrasound. The non-radioactivity, efficiency, repeatability and 3D reconstruction offered by this ultrasound system are just a few of its many advantages. Demand will rise as patient preference for minimally invasive diagnostic procedures increases. Real-time imaging support enables the chain of command. Other benefits of ABVS include faster, less painful surgery and improved diagnostic accuracy, leading to earlier breast cancer diagnosis. The results of this technique can be used for insightful preoperative surgical planning. The hospital segment accounted for the highest share in 2020 and is expected to maintain this trend over the forecast period owing to increasing patient population, faster availability of medical instruments and equipment, and presence of skilled personnel. The use of ABUS in hospitals is receiving increasing attention as a means of meeting the diagnostic needs of patients. Increased awareness of regular cancer screening tests among young and middle-aged women will drive demand for ABUS and ABVS in these healthcare facilities as pregnant women are unable to undergo mammograms due to radiation risks and hospitals are installing ABUS to provide a safer diagnostic option .
This report is a detailed and comprehensive analysis for global Automatic Breast Ultrasound Diagnosis Systems market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Automatic Breast Ultrasound Diagnosis Systems market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (K USD/Unit), 2020-2031
Global Automatic Breast Ultrasound Diagnosis Systems market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (K USD/Unit), 2020-2031
Global Automatic Breast Ultrasound Diagnosis Systems market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (K USD/Unit), 2020-2031
Global Automatic Breast Ultrasound Diagnosis Systems market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (K USD/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Automatic Breast Ultrasound Diagnosis Systems
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Automatic Breast Ultrasound Diagnosis Systems market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GE Healthcare, Siemens, Hitachi, SonoCiné, Koninklijke Philips, QView Medical, Seno Medical Instruments, Volpara Solutions, Delphinus Medical Technologies, CapeRay, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Automatic Breast Ultrasound Diagnosis Systems market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Automated Breast Ultrasound Systems
Automated Breast Volume Scanner
Market segment by Application
Hospitals
Diagnostic Imaging Laboratories
Major players covered
GE Healthcare
Siemens
Hitachi
SonoCiné
Koninklijke Philips
QView Medical
Seno Medical Instruments
Volpara Solutions
Delphinus Medical Technologies
CapeRay
SuperSonic Imagine
Nova Medical Imaging Technology
SIUI
Theraclion
Real Imaging
MetriTrack
Toshiba
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Automatic Breast Ultrasound Diagnosis Systems product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Automatic Breast Ultrasound Diagnosis Systems, with price, sales quantity, revenue, and global market share of Automatic Breast Ultrasound Diagnosis Systems from 2020 to 2025.
Chapter 3, the Automatic Breast Ultrasound Diagnosis Systems competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Automatic Breast Ultrasound Diagnosis Systems breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Automatic Breast Ultrasound Diagnosis Systems market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Automatic Breast Ultrasound Diagnosis Systems.
Chapter 14 and 15, to describe Automatic Breast Ultrasound Diagnosis Systems sales channel, distributors, customers, research findings and conclusion.
Automated breast ultrasound diagnostic systems are used as an adjunct to mammography to screen for breast cancer in asymptomatic women with dense breasts. It is an effective screening modality that can differentiate between cysts, fibroadenomas, cancer or infection. The size of the lesion can be measured, the exact location is easily determined, or it can be precisely positioned for surgical procedures.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. The automated breast volume scanner (ABVS) segment is expected to hold the largest share during the forecast period, ABVS uses a scanner to precisely examine lactiferous ducts and evaluate breast volume images by high frequency ultrasound. The non-radioactivity, efficiency, repeatability and 3D reconstruction offered by this ultrasound system are just a few of its many advantages. Demand will rise as patient preference for minimally invasive diagnostic procedures increases. Real-time imaging support enables the chain of command. Other benefits of ABVS include faster, less painful surgery and improved diagnostic accuracy, leading to earlier breast cancer diagnosis. The results of this technique can be used for insightful preoperative surgical planning. The hospital segment accounted for the highest share in 2020 and is expected to maintain this trend over the forecast period owing to increasing patient population, faster availability of medical instruments and equipment, and presence of skilled personnel. The use of ABUS in hospitals is receiving increasing attention as a means of meeting the diagnostic needs of patients. Increased awareness of regular cancer screening tests among young and middle-aged women will drive demand for ABUS and ABVS in these healthcare facilities as pregnant women are unable to undergo mammograms due to radiation risks and hospitals are installing ABUS to provide a safer diagnostic option .
This report is a detailed and comprehensive analysis for global Automatic Breast Ultrasound Diagnosis Systems market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Automatic Breast Ultrasound Diagnosis Systems market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (K USD/Unit), 2020-2031
Global Automatic Breast Ultrasound Diagnosis Systems market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (K USD/Unit), 2020-2031
Global Automatic Breast Ultrasound Diagnosis Systems market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (K USD/Unit), 2020-2031
Global Automatic Breast Ultrasound Diagnosis Systems market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (K USD/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Automatic Breast Ultrasound Diagnosis Systems
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Automatic Breast Ultrasound Diagnosis Systems market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GE Healthcare, Siemens, Hitachi, SonoCiné, Koninklijke Philips, QView Medical, Seno Medical Instruments, Volpara Solutions, Delphinus Medical Technologies, CapeRay, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Automatic Breast Ultrasound Diagnosis Systems market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Automated Breast Ultrasound Systems
Automated Breast Volume Scanner
Market segment by Application
Hospitals
Diagnostic Imaging Laboratories
Major players covered
GE Healthcare
Siemens
Hitachi
SonoCiné
Koninklijke Philips
QView Medical
Seno Medical Instruments
Volpara Solutions
Delphinus Medical Technologies
CapeRay
SuperSonic Imagine
Nova Medical Imaging Technology
SIUI
Theraclion
Real Imaging
MetriTrack
Toshiba
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Automatic Breast Ultrasound Diagnosis Systems product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Automatic Breast Ultrasound Diagnosis Systems, with price, sales quantity, revenue, and global market share of Automatic Breast Ultrasound Diagnosis Systems from 2020 to 2025.
Chapter 3, the Automatic Breast Ultrasound Diagnosis Systems competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Automatic Breast Ultrasound Diagnosis Systems breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Automatic Breast Ultrasound Diagnosis Systems market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Automatic Breast Ultrasound Diagnosis Systems.
Chapter 14 and 15, to describe Automatic Breast Ultrasound Diagnosis Systems sales channel, distributors, customers, research findings and conclusion.
Table of Contents
138 Pages
- 1 Market Overview
- 2 Manufacturers Profiles
- 3 Competitive Environment: Automatic Breast Ultrasound Diagnosis Systems by Manufacturer
- 4 Consumption Analysis by Region
- 5 Market Segment by Type
- 6 Market Segment by Application
- 7 North America
- 8 Europe
- 9 Asia-Pacific
- 10 South America
- 11 Middle East & Africa
- 12 Market Dynamics
- 13 Raw Material and Industry Chain
- 14 Shipments by Distribution Channel
- 15 Research Findings and Conclusion
- 16 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
